# Kineticos Ventures

Kineticos Ventures is a Venture Capital based in Raleigh, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Raleigh, United States
- **Region:** North America
- **Address:** Raleigh, NC, United States
- **Founded:** 2005
- **Assets under management:** Undisclosed
- **Website:** kineticos.com
- **LinkedIn:** https://www.linkedin.com/company/kineticos

## Regulatory record

- **Reports private funds:** No

## About

Kineticos Ventures invests in life-science businesses. It evaluates opportunities in cell and gene therapy and antimicrobial resistance. The firm provides investment analysis, financial modeling, commercial due diligence, and market research support to its portfolio companies.

## Sectors

- Life Sciences
- Cell and Gene Therapy
- Antimicrobial Resistance
- Biotech

## People

- Frank Lis — President and CEO

## Questions

### Who makes investment decisions at Kineticos Ventures?

Frank Lis, the founder, serves as President and CEO and is the central decision-maker on investments. The firm operates with a flat structure, and its team draws heavily from the Kineticos Life Sciences consultancy, giving clinical and regulatory experts direct input into deal evaluation.

### How does the Kineticos consultancy relationship work with the venture arm?

Kineticos Life Sciences is an established life-science advisory firm that predates or operates alongside the Ventures arm. The consultancy generates revenue from biotech and diagnostics companies on strategy, market access, and M&A mandates. That revenue stream reduces reliance on management fees, and advisory clients periodically become investment prospects or co-development partners for portfolio companies.

### Does Kineticos Ventures invest only in Research Triangle companies?

No. While the firm is anchored in Raleigh and draws significant deal flow from the university and hospital networks of North Carolina's Research Triangle, its investments and advisory engagements are national. It has also evaluated opportunities in European biotech, particularly firms seeking US commercialization pathways.

### What stage of company does Kineticos typically target?

The firm concentrates on seed and early-stage rounds, where scientific assets have emerged from academic labs or initial preclinical work but lack the commercial infrastructure to advance. It frequently gets involved before a traditional Series A syndicate forms, providing capital and operational scaffolding concurrently.

### Is Kineticos Ventures structured as a single-fund entity?

The firm has not publicly disclosed its fund structure or whether capital is deployed from a committed blind-pool fund, a series of SPVs, or a hybrid evergreen vehicle. Its public posture emphasizes the integrated consultancy, which distinguishes its economics from a typical closed-end venture fund.

## Related profiles

- [Kinetic Capital Partners](https://altss.com/profile/kinetic-capital-partners)
- [Kinetic Ventures](https://altss.com/profile/kinetic-ventures)

---

Last updated: 2026-07-11T16:27:09.000Z

Canonical page: https://altss.com/profile/kineticos-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology